Article

Nov. 15 deadline for Pediatric Cataract Initiative grant application

The American Medical Association (AMA) has published a new Current Procedural Terminology (CPT) code that applies to a proprietary osmolarity test (TearLab),

Chicago-Nov. 15 is the deadline for receipt of the Pediatric Cataract Initiative inaugural research grant applications.

One qualified individual, institution, or organization investigating the causes of pediatric cataract and/or improved treatment tools and protocols will receive $75,000.

The grant will support research that can be carried out in 12 months with limited resources. It is not geography-dependent, although the research should have a degree of applicability regionally or globally, according to the organization. Applicants may submit more than one proposal, provided that each is scientifically distinct. Interested parties may visit www.pediatriccataract.org/grant_funding to download the complete request for proposals.

The initiative is a partnership between the Bausch + Lomb Early Vision Institute and the Lions Clubs International Foundation. In addition to its non-geography-specific research grant, the initiative is committing funding and support during its first year to innovative, scalable prevention and treatment programs in the People’s Republic of China, where at least 40,000 children are estimated to have pediatric cataract.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times) ASCRS 2025: Mark Lobanoff, MD, on making the move to office-based surgery
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.